FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4296622903> ?p ?o ?g. }

• W4296622903 endingPage "612" @default.
• W4296622903 startingPage "602" @default.
• W4296622903 abstract "γ-H2AX and 53BP1 are fundamental for cellular DNA damage response (DDR) after radiation exposure and are linked to cell repair, arrest, or apoptosis. We aimed to evaluate whether DDR-markers in peripheral blood lymphocytes (PBLs) may have predictive potential for outcome in metastatic castration-resistant prostate cancer (mCRPC) patients receiving [177Lu]Lu-prostate-specific membrane antigen (PSMA) radioligand therapy (RLT).We prospectively enrolled 20 men with advanced mCRPC scheduled for PSMA-targeted RLT. Prior to the first cycle of [177Lu]Lu-PSMA RLT, all patients underwent [18F]F-PSMA-1007 positron emission tomography (PET)/computed tomography (CT) for assessment of tumor PSMA expression (assessing maximum standardized uptake value (SUVmax) of all tumor lesions). Blood samples were collected prior to, + 1 h after, and + 24 h after administration of [177Lu]Lu-PSMA, and DDR-markers γ-H2AX and 53BP1 were determined in PBLs through immunocytofluorescence. We then tested the predictive performance of DDR-markers relative to clinical and PET-based parameters for progressive disease (PSA-PD) after 2 cycles. In addition, the predictive value for progression-free survival (PSA-PFS, provided as median and 95% confidence interval [CI]) was explored.Low baseline 53BP1 and γ-H2AX foci (P = 0.17) tended to predict early PSA-PD, whereas low SUVmax was significantly associated with higher risk for PSA-PD (P = 0.04). In Kaplan-Meier analysis, there was a trend towards prolonged PSA-PFS in patients with higher baseline 53BP1 of 6 months (mo; 95%CI, 4-9 mo) compared to 3 mo in patients with low 53BP1 (95% CI, 2-3 mo; P = 0.12). Comparable results were recorded for higher γ-H2AX expression (6 mo [95% CI, 3-9 mo] relative to 3 mo [95% CI, 2-4 mo] in patients with low γ-H2AX; P = 0.12). SUVmax, however, did not demonstrate predictive value (P = 0.29). Consistently, in univariate Cox-regression analysis, baseline 53BP1 foci demonstrated borderline significance for predicting PSA-PFS under [177Lu]Lu-PSMA RLT (P = 0.05).In this prospective study investigating mCRPC patients undergoing [177Lu]Lu-PSMA RLT, low baseline DDR-markers in PBLs tended to predict poor outcome. Although the study group was small and results need further confirmation, these preliminary findings lay the foundation for exploring additive radiosensitizing or treatment intensification in future studies with high-risk individuals scheduled for RLT." @default.
• W4296622903 created "2022-09-23" @default.
• W4296622903 creator A5010436347 @default.
• W4296622903 creator A5014956643 @default.
• W4296622903 creator A5019238828 @default.
• W4296622903 creator A5029977875 @default.
• W4296622903 creator A5031324764 @default.
• W4296622903 creator A5074150271 @default.
• W4296622903 creator A5076098051 @default.
• W4296622903 date "2022-09-22" @default.
• W4296622903 modified "2023-10-14" @default.
• W4296622903 title "Individual radiosensitivity reflected by γ-H2AX and 53BP1 foci predicts outcome in PSMA-targeted radioligand therapy" @default.
• W4296622903 cites W1969474286 @default.
• W4296622903 cites W1999671728 @default.
• W4296622903 cites W2126898119 @default.
• W4296622903 cites W2127733528 @default.
• W4296622903 cites W2133223019 @default.
• W4296622903 cites W2149309158 @default.
• W4296622903 cites W2183147143 @default.
• W4296622903 cites W2278392405 @default.
• W4296622903 cites W2499065405 @default.
• W4296622903 cites W2523192478 @default.
• W4296622903 cites W2614800517 @default.
• W4296622903 cites W2623030379 @default.
• W4296622903 cites W2743412658 @default.
• W4296622903 cites W2781816512 @default.
• W4296622903 cites W2794677852 @default.
• W4296622903 cites W2799931007 @default.
• W4296622903 cites W2899540665 @default.
• W4296622903 cites W2900829249 @default.
• W4296622903 cites W2918598437 @default.
• W4296622903 cites W2924617625 @default.
• W4296622903 cites W2941372839 @default.
• W4296622903 cites W2969742213 @default.
• W4296622903 cites W2982404765 @default.
• W4296622903 cites W2996142297 @default.
• W4296622903 cites W3008895328 @default.
• W4296622903 cites W3010388685 @default.
• W4296622903 cites W3012316871 @default.
• W4296622903 cites W3040097601 @default.
• W4296622903 cites W3046584472 @default.
• W4296622903 cites W3093769459 @default.
• W4296622903 cites W3107412089 @default.
• W4296622903 cites W3118680690 @default.
• W4296622903 cites W3130934287 @default.
• W4296622903 cites W3133507743 @default.
• W4296622903 cites W3136209958 @default.
• W4296622903 cites W3154599308 @default.
• W4296622903 cites W3156207511 @default.
• W4296622903 cites W3158713318 @default.
• W4296622903 cites W3165438751 @default.
• W4296622903 cites W3170474498 @default.
• W4296622903 cites W3170886129 @default.
• W4296622903 cites W3176208875 @default.
• W4296622903 cites W3180641083 @default.
• W4296622903 doi "https://doi.org/10.1007/s00259-022-05974-8" @default.
• W4296622903 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36136101" @default.
• W4296622903 hasPublicationYear "2022" @default.
• W4296622903 type Work @default.
• W4296622903 citedByCount "5" @default.
• W4296622903 countsByYear W42966229032023 @default.
• W4296622903 crossrefType "journal-article" @default.
• W4296622903 hasAuthorship W4296622903A5010436347 @default.
• W4296622903 hasAuthorship W4296622903A5014956643 @default.
• W4296622903 hasAuthorship W4296622903A5019238828 @default.
• W4296622903 hasAuthorship W4296622903A5029977875 @default.
• W4296622903 hasAuthorship W4296622903A5031324764 @default.
• W4296622903 hasAuthorship W4296622903A5074150271 @default.
• W4296622903 hasAuthorship W4296622903A5076098051 @default.
• W4296622903 hasBestOaLocation W42966229031 @default.
• W4296622903 hasConcept C121608353 @default.
• W4296622903 hasConcept C126322002 @default.
• W4296622903 hasConcept C126894567 @default.
• W4296622903 hasConcept C143998085 @default.
• W4296622903 hasConcept C170493617 @default.
• W4296622903 hasConcept C2775842073 @default.
• W4296622903 hasConcept C2780192828 @default.
• W4296622903 hasConcept C2989005 @default.
• W4296622903 hasConcept C44249647 @default.
• W4296622903 hasConcept C67847695 @default.
• W4296622903 hasConcept C71924100 @default.
• W4296622903 hasConceptScore W4296622903C121608353 @default.
• W4296622903 hasConceptScore W4296622903C126322002 @default.
• W4296622903 hasConceptScore W4296622903C126894567 @default.
• W4296622903 hasConceptScore W4296622903C143998085 @default.
• W4296622903 hasConceptScore W4296622903C170493617 @default.
• W4296622903 hasConceptScore W4296622903C2775842073 @default.
• W4296622903 hasConceptScore W4296622903C2780192828 @default.
• W4296622903 hasConceptScore W4296622903C2989005 @default.
• W4296622903 hasConceptScore W4296622903C44249647 @default.
• W4296622903 hasConceptScore W4296622903C67847695 @default.
• W4296622903 hasConceptScore W4296622903C71924100 @default.
• W4296622903 hasFunder F4320320879 @default.
• W4296622903 hasFunder F4320321672 @default.
• W4296622903 hasIssue "2" @default.
• W4296622903 hasLocation W42966229031 @default.
• W4296622903 hasLocation W42966229032 @default.
• W4296622903 hasLocation W42966229033 @default.

• next